Skin News and Research

RSS

Canadian woman dies of flesh eating disease

A Canadian women has died and another patient is in a serious condition following an outbreak of so-called "flesh-eating disease" in Canada.

2 May 2004

Warning to parents-to-be that non-medical ultrasounds are unapproved, inappropriate, and possibly even risky

For many expectant parents, ultrasounds offer a window into the world of their growing unborn baby. Unlike most standard prenatal tests that involve nothing more than a urine cup or a needle

1 May 2004

FDA approves new drug Enbrel for psoriasis

The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.

1 May 2004

UK, skin cancer specialists to check out moles

Macmillan skin cancer nurse, Denise Hancock, and colleagues from the Dermatology Department at Southampton University Hospitals Trust are inviting members of the public to 'check out their moles' at a Mole Watch Day in Marks and Spencer in West Quay on Wednesday 12 May, from 9am-5pm.

30 Apr 2004

Gene therapy may delay Alzheimer progression

Results from a preliminary eight-patient study of gene therapy for Alzheimer’s disease are positive enough to justify a larger clinical trial, Mark H. Tuszynski, M.D., Ph.D., reported April 27 at the 56th Annual Meeting of the American Academy of Neurology. Dr. Tuszynski says that a larger trial is being planned at a major medical center in Chicago.

30 Apr 2004

Researchers find mucus plays key role in cancer

Investigators at the Dana-Farber/Harvard Cancer Center in Boston became intrigued with the thick, slimy stuff when they learned that breast, lung, colon, and other tumor cells make more than 50 times more of a certain type of it than normal cells.

29 Apr 2004

A popular supplement, coenzyme Q10 (CoQ10), may help prevent migraine

Migraine patients who took 100 mg three times a day of CoQ10—which acts as the body’s energy producer—had fewer attacks in three months than those who took a placebo. The participants taking CoQ10 also had fewer days with a headache and fewer days with nausea.

28 Apr 2004

Results look promising in Alzheimer’s gene therapy trial

Surgical placement of genetically modified tissue directly into the brains of patients with Alzheimer’s disease, an experimental approach to delaying brain cell loss associated with the disease, leads to increased metabolic activity in the brain, with cells apparently responding to the insertion of growth factor-producing grafts

28 Apr 2004

Tips to avoid Lyme disease and West Nile virus

What's bugging you now that spring is here? Probably the same thing that's bugging your child -– mosquitoes, ticks and other flying, crawling, or creeping creatures of the great outdoors. Not only are these bugs' bites and stings painful and itchy, the potential health risk of insect-borne diseases -- such as Lyme disease and West Nile virus

28 Apr 2004

Women who exercise need to be aware of health issues relating to hygiene

Nearly 80 percent of women exercise on a regular basis, yet as much as one-third of these women mistakenly wear their sweat-soaked clothes for as long as an hour following a workout, according to a new survey by Harris Interactive for the Vagisil Women's Health Center(R) (VWHC).

28 Apr 2004

Menopause often wrongly blamed for poor sleep

Middle-aged women often complain that they sleep poorly, and both women and their health care providers point to menopause as the cause. But University of Michigan researchers Jane Lukacs and Nancy Reame say it may be time to put that assumption to rest.

27 Apr 2004

Psoriasis medications can treat more than the skin

The National Psoriasis Foundation, Dermatology Nurses Association, Dermatologists and People with Psoriasis have collaborated to offer a new resource to help people with psoriasis cope with the social and emotional impact of psoriasis.

27 Apr 2004

California has set a public health goal for arsenic levels in drinking water

The California Environmental Protection Agency’s Office of Environmental Health Hazard Assessment (OEHHA) today announced the publication of a final Public Health Goal (PHG) for arsenic in drinking water.

27 Apr 2004

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Helix BioMedix today announced that it has completed a 12-week consumer product test comparing the company's anti-wrinkle peptide, HB168 with Renova(R), a currently marketed FDA approved product.

27 Apr 2004

Hand surgeons warn of gardening dangers

The American Society for Surgery of the Hand (ASSH) recommends gardeners take the proper precautions to prevent hand-related injuries before digging or planting in the garden this spring. According to the Consumer Product Safety Commission (CPSC), emergency rooms treat more than 400,000 outdoor garden-tool-related accidents each year.

27 Apr 2004

Biological bandages are being successfully used to treat patients with severe burns

Doctors have been impressed with the rapid recovery rates instigated by the ‘tailor-made ’ discs, which have been devised by a research team at the Sheffield company, CellTran, with financial support from the Wellcome Trust biomedical research charity and the White Rose Technology Seedcorn Fund. They will be officially launched at the British Burn Association’s annual meeting in Manchester tomorrow (28th).

27 Apr 2004

WHO calls for Sudan humanitarian assistance

Intensified and urgent action is needed in the Greater Darfur Region of western Sudan to address one of the most severe humanitarian emergencies today. Given the current situation, the humanitarian crisis will last several months.

23 Apr 2004

Skin cancer is now the UK's most common cancer in both men and women

Macmillan skin cancer nurse specialists will be promoting sun awareness and the dangers of skin cancer during Sun Awareness Week which runs from 10 to 16 May.

23 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

The April 2004 issue of Otolaryngology focuses on head and neck surgery

The efficacy of a new cancer-fighting virus is tested in the study, “Treatment of Solid Sarcomas in Immunocompetent Mice with Novel Oncolytic Herpes Simplex Viruses.” A team of multi-disciplinary Japanese researchers found that a weakened version of herpes simplex virus (HSV) effectively eradicated neck and flank tumors in mice.

23 Apr 2004